Goldline Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Nagpur, Maharashtra, India, established in 2004.
2004 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Goldline Pharmaceutical Limited

Goldline Pharmaceutical Limited, a active public limited company, was established on 02 August 2004 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51397MH2004PLC147806. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹8.71 Cr.

Formerly known as Goldline Pharmaceutical Private Limited. It upholds a compliant status. Employing 85 professional, Its leadership includes Swapan Khandelwal (Whole-Time Director), Amol Laxmikant Mujumdar (Managing Director), Mehul Hari Ranade (Director). Past directors included Girish Damodar Kalamkar, Swapan Khandelwal, Amol Laxmikant Mujumdar. It holds ₹8.54 Cr open charges and ₹3.53 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 103,F-1Leelaapartmentshilpahsgsociety,Nearsaptagirinagar,Shanidham,Narend, Ra Nagar,, Nagpur, Maharashtra, 440015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397MH2004PLC147806

  • Registration Number

    147806

  • Incorporation Date

    02 August 2004

  • Authorized Capital

    ₹13.50 Cr

  • Paid-Up Capital

    ₹8.71 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 13.50 Cr
  • Paid Up Capital ₹ 8.71 Cr
  • Company Age 21 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.54 Cr
  • Satisfied Charges ₹ 3.53 Cr
Company report

Goldline Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Goldline Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Goldline Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Swapan Khandelwal Whole-Time Director 11 Apr 2011 Current
Amol Laxmikant Mujumdar Managing Director 02 Aug 2004 Current
Mehul Hari Ranade Director 30 Sep 2024 Current
Prashant Shrikrishna Karkare Director 16 Jul 2013 Current
Renuka Saurabh Borole Director 30 Sep 2024 Current
Shraddha Kiran Kulkarni Director 17 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 12 Apr 2011 Past
Pramod Abcsdd Director 10 Nov 2021 Past
Pramod Abcsdd Director 01 Apr 2009 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 09 Mar 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Goldline Pharmaceutical.

Goldline Pharmaceutical Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Goldline Pharmaceutical revenue growth over time
Goldline Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Goldline Pharmaceutical?

In 2023, Goldline Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹85,350,000.00

Satisfied Charges

₹35,300,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 8.11 Cr
  • Others : 0.42 Cr
Latest Charge Details
Date Lender Amount Status
12 Dec 2024 Others ₹4.21 M Open
02 May 2022 Bank Of India ₹4.60 M Open
16 Jan 2013 Bank Of India ₹7.65 Cr Open
27 Dec 2013 Bank Of India ₹0.80 M Satisfied
17 Feb 2011 State Bank Of India ₹3.45 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Goldline Pharmaceutical?

Goldline Pharmaceutical has a workforce of 85 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Goldline Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldline Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Goldline Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Goldline Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Goldline Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Dipti Sharad Bhusari was appointed as a Cfo was appointed as a Cfo on 17 Jan 2025 & has been associated with this company since 1 year 2 months . was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.42 Cr with Charge ID 101015954 was registered on 12 Dec 2024. was documented.

  • Charges

    Progress on A charge registered on 27 Dec 2013 via Charge ID 100814496 with Bank Of India was fully satisfied on 05 Dec 2024. was documented.

  • Director Appointment

    Progress on Ruchi Sanket Modi was appointed as a Company Secretary was appointed as a Company Secretary on 05 Nov 2024 & has been associated with this company since 1 year 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Goldline Pharmaceutical Limited?

The CIN of Goldline Pharmaceutical Limited is U51397MH2004PLC147806.

Where is Goldline Pharmaceutical Limited headquartered?

Goldline Pharmaceutical Limited is headquartered at 103,F-1Leelaapartmentshilpahsgsociety,Nearsaptagirinagar,Shanidham,Narend, Ra Nagar,, Nagpur, Maharashtra, 440015.

When was Goldline Pharmaceutical Limited incorporated?

Goldline Pharmaceutical Limited was incorporated on 02 August 2004.

Who are the current directors of Goldline Pharmaceutical Limited?

The current directors of Goldline Pharmaceutical Limited are

What is the primary industry of Goldline Pharmaceutical Limited?

The primary industry of Goldline Pharmaceutical Limited is Manufacturing.

Is Goldline Pharmaceutical Limited a listed company?

Goldline Pharmaceutical Limited is unlisted.

What is the capital structure of Goldline Pharmaceutical Limited?

The authorized capital of Goldline Pharmaceutical Limited is ₹13.50 Cr, and the paid-up capital is ₹8.71 Cr.

What is the compliance status of Goldline Pharmaceutical Limited?

The compliance status of Goldline Pharmaceutical Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available